$CBDW
1606 CORP. Stock $cbdw

$cbdw Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000147793224002182 Filed on April 17, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$0.00		$1.603K
YoY Change	-100.0%		-88.5%
Cost Of Revenue	$0.00		$995.00
YoY Change	-100.0%		-92.2%
Gross Profit	$0.00		$608.00
YoY Change	-100.0%		-48.56%
Gross Profit Margin			37.93%
Selling, General & Admin	$288.7K		$1.709M
YoY Change	-28.34%		1596.46%
% of Gross Profit			281101.97%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$288.7K		$1.774M
YoY Change	-38.29%		227.8%
Operating Profit	-$288.7K		-$1.773M
YoY Change	-38.72%		228.4%
Interest Expense	$128.4K
YoY Change	4994.61%
% of Operating Profit
Other Income/Expense, Net	-$50.45K		$192.8K
YoY Change	1901.31%
Pretax Income	-$339.2K		-$1.581M
YoY Change	-28.01%		192.71%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$339.2K		-$1.581M
YoY Change	-28.01%		192.71%
Net Earnings / Revenue			-98610.92%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	65.36M shares	47.26M shares	47.32M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$75.00K	$48.94K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$72.77K	$72.85K
Prepaid Expenses
Receivables	$2.762K	$3.600K
Other Receivables
Total Short-Term Assets	$195.7K	$148.3K
YoY Change	7.94%	-36.01%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$195.7K	$148.3K
Total Long-Term Assets	$0.00	$0.00
Total Assets	$195.7K	$148.3K
YoY Change	7.94%	-36.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$897.7K	$612.7K
YoY Change	2.93%	-25.9%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$950.6K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$897.7K	$612.7K
Total Long-Term Liabilities		$950.6K
Total Liabilities	$2.118M	$1.563M
YoY Change		89.06%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.048M	-$2.422M
YoY Change	97.56%	187.89%
Common Stock	$7.554K	$5.858K
YoY Change	63.65%	56.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.923M	-$1.415M
YoY Change
Total Liabilities & Shareholders Equity	$195.7K	$148.3K
YoY Change	7.94%	-36.01%

Cashflow Statement

Concept	2024 Q2	2023
OPERATING ACTIVITIES
Net Income	-$339.2K	-$1.581M
YoY Change	-28.01%	192.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities		-$747.1K
YoY Change		22.45%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$86.50K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$412.5K
YoY Change		153.85%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$777.5K
YoY Change		10.18%
NET CHANGE
Cash From Operating Activities		-$747.1K
Cash From Investing Activities		-$86.50K
Cash From Financing Activities		$777.5K
Net Change In Cash		-$56.12K
YoY Change		-158.76%
FREE CASH FLOW
Cash From Operating Activities		-$747.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.210	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	537032	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	265673	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	265673	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	537032	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001877461
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Security12g Title Security12gTitle	Common Stock, Par value $0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	58582469	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37428394	shares
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023	onesix	Convertible Promissory Note Term ConvertiblePromissoryNoteTerm	P1Y
CY2022Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.0001
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-53425
CY2023	dei	Entity Registrant Name EntityRegistrantName	1606 Corp.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-1497346
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2425 E. Camelback Rd Suite 150
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Phoenix
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85016
CY2023	dei	City Area Code CityAreaCode	602
CY2023	dei	Local Phone Number LocalPhoneNumber	481-1544
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	us-gaap	Revenues Revenues	13944	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	995	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12762	usd
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	170152	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	65356177	shares
CY2023	dei	Auditor Firm AuditorFirmId	76
CY2023	dei	Auditor Name AuditorName	Turner, Stone & Company, L.L.P.
CY2023	dei	Auditor Location AuditorLocation	Dallas, Texas
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	48941	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	105065	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	3600	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	21500	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	0	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	72853	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	113174	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1444	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13577	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	148338	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	231816	usd
CY2023Q4	us-gaap	Assets Assets	148338	usd
CY2022Q4	us-gaap	Assets Assets	231816	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	295041	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	25188	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	10086	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3173	usd
CY2023Q4	onesix	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent	63456	usd
CY2022Q4	onesix	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent	63456	usd
CY2023Q4	onesix	Convertible Notes Net Of Discount ConvertibleNotesNetOfDiscount	51086	usd
CY2022Q4	onesix	Convertible Notes Net Of Discount ConvertibleNotesNetOfDiscount	0	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	193026	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	612695	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	91817	usd
CY2023Q4	onesix	Note Payable To Shareholder NotePayableToShareholder	950550	usd
CY2022Q4	onesix	Note Payable To Shareholder NotePayableToShareholder	735050	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	950550	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	735050	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1563245	usd
CY2022Q4	us-gaap	Liabilities Liabilities	826867	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58582469	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37428394	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	5858	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3742	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	995638	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	236842	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2422031	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-841298	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1414907	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-595051	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	148338	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	231816	usd
CY2023	us-gaap	Revenues Revenues	1603	usd
CY2023	us-gaap	Gross Profit GrossProfit	608	usd
CY2022	us-gaap	Gross Profit GrossProfit	1182	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1709100	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	541219	usd
CY2023	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	65000	usd
CY2022	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	0	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	1774100	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	541219	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1773492	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-540037	usd
CY2023	onesix	Derivative Liability At Fair Value Changes In Fair Value DerivativeLiabilityAtFairValueChangesInFairValue	-192759	usd
CY2022	onesix	Derivative Liability At Fair Value Changes In Fair Value DerivativeLiabilityAtFairValueChangesInFairValue	0	usd
CY2023	us-gaap	Other Expenses OtherExpenses	192759	usd
CY2022	us-gaap	Other Expenses OtherExpenses	0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1580733	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-540037	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1580733	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-540037	usd
CY2023	onesix	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.03
CY2022	onesix	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.01
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47322946	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37144459	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-217514	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-540037	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-595051	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-595051	usd
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	usd
CY2023	onesix	Preferred Stock Issued For Services Amount PreferredStockIssuedForServicesAmount	110002	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	412500	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	178544	usd
CY2023	onesix	Settlement Of Derivative Liability SettlementOfDerivativeLiability	59831	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1580733	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-1414907	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1580733	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-540037	usd
CY2023	onesix	Shares Issued For Services Provided Value SharesIssuedForServicesProvidedValue	-288546	usd
CY2022	onesix	Shares Issued For Services Provided Value SharesIssuedForServicesProvidedValue	0	usd
CY2023	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	65000	usd
CY2022	us-gaap	Loss On Sale Of Investments LossOnSaleOfInvestments	0	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	119324	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2023	us-gaap	Financing Interest Expense FinancingInterestExpense	200616	usd
CY2022	us-gaap	Financing Interest Expense FinancingInterestExpense	0	usd
CY2023	onesix	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	192759	usd
CY2022	onesix	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3600	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-40321	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	81725	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-12133	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	13577	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	269852	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	25188	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	29195	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-747104	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-610151	usd
CY2023	onesix	Proceeds From Investment In Operating Companies ProceedsFromInvestmentInOperatingCompanies	65000	usd
CY2022	onesix	Proceeds From Investment In Operating Companies ProceedsFromInvestmentInOperatingCompanies	0	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	21500	usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-86500	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	215500	usd
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	543173	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	245000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	95520	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	412500	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	162500	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	777480	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	705673	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-56124	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	95522	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105065	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9543	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48941	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105065	usd
CY2023	us-gaap	Interest Paid InterestPaid	0	usd
CY2022	us-gaap	Interest Paid InterestPaid	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	onesix	Non Cash Activities Discount On Convertible Notes Payable From Derivative Liability NonCashActivitiesDiscountOnConvertibleNotesPayableFromDerivativeLiability	141231	usd
CY2022	onesix	Non Cash Activities Discount On Convertible Notes Payable From Derivative Liability NonCashActivitiesDiscountOnConvertibleNotesPayableFromDerivativeLiability	0	usd
CY2023	onesix	Non Cash Activities Settlement Of Derivative Liability NonCashActivitiesSettlementOfDerivativeLiability	59831	usd
CY2022	onesix	Non Cash Activities Settlement Of Derivative Liability NonCashActivitiesSettlementOfDerivativeLiability	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results may differ from those estimates.</p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	onesix	Common Stock Share Outstanding CommonStockShareOutstanding	58582469	shares
CY2022Q4	onesix	Common Stock Share Outstanding CommonStockShareOutstanding	37428394	shares
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1709100	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	541219	usd
CY2022Q4	us-gaap	Servicing Liability At Amortized Value Balance ServicingLiabilityAtAmortizedValueBalance	0	usd
CY2023	us-gaap	Servicing Liability At Amortized Value Additions ServicingLiabilityAtAmortizedValueAdditions	445616	usd
CY2023	onesix	Servicing Liability At Amortized Value Settlements ServicingLiabilityAtAmortizedValueSettlements	-59831	usd
CY2023	us-gaap	Servicing Liability At Amortized Value Period Increase Decrease ServicingLiabilityAtAmortizedValuePeriodIncreaseDecrease	-192759	usd
CY2023Q4	us-gaap	Servicing Liability At Amortized Value Balance ServicingLiabilityAtAmortizedValueBalance	193026	usd
CY2023Q4	us-gaap	Share Price SharePrice	0.0285
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.0182
CY2023	us-gaap	Common Stock Voting Rights CommonStockVotingRights	The holders of common stock are entitled to one vote for each share held
CY2023	onesix	Common Stock Issued In Payment Shares CommonStockIssuedInPaymentShares	6518950	shares
CY2023Q4	onesix	Promissory Note Related Party Current PromissoryNoteRelatedPartyCurrent	950550	usd
CY2023Q4	onesix	Promissory Note Related Party Current PromissoryNoteRelatedPartyCurrent	950550	usd
CY2023Q4	us-gaap	Convertible Subordinated Debt ConvertibleSubordinatedDebt	204488	usd
CY2023	onesix	Description Of Conversion Price DescriptionOfConversionPrice	conversion price equal to 65% of the lowest trading price for the common stock during the ten-day period prior to the conversion date
CY2023	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	9476	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3653	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	20323	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	178653	usd
CY2023	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	2714	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	445616	usd
	onesix	Additional Debt Discounts AdditionalDebtDiscounts	249000	usd
CY2023	onesix	Settlement Of Derivative Liabilities SettlementOfDerivativeLiabilities	59831	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	114542	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	950550	usd
CY2023Q4	onesix	Long Term Debt Maturities Repayments Of Principal LongTermDebtMaturitiesRepaymentsOfPrincipal	1065092	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.0001
CY2023Q4	onesix	Preferred Stock Shares Issued Related To Class A PreferredStockSharesIssuedRelatedToClassA	56282599	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	58582469	shares
CY2023	onesix	Common Stock Issued In Payment Amount CommonStockIssuedInPaymentAmount	178544	usd
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	13810125	shares
CY2023	onesix	Share Conversions Shares ShareConversionsShares	552405	shares
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	825000	shares
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.50
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	412500	shares
CY2022	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	325000	shares
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.50
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	162500	shares
CY2023Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1.00
CY2023	us-gaap	Preferred Stock Voting Rights PreferredStockVotingRights	Each share of Class A preferred stock entitles the holder thereof to 50 votes on any matters requiring a shareholder vote of the Company
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.210	pure
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	537032	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	265673	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd

Files In Submission

Name	View Source	Status
0001477932-24-002182-index-headers.html	Edgar Link	pending
0001477932-24-002182-index.html	Edgar Link	pending
0001477932-24-002182.txt	Edgar Link	pending
0001477932-24-002182-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
onesix-20231231.xsd	Edgar Link	pending
onesix_10k.htm	Edgar Link	pending
onesix_10kimg1.jpg	Edgar Link	pending
onesix_10kimg2.jpg	Edgar Link	pending
onesix_ex1010.htm	Edgar Link	pending
onesix_ex109.htm	Edgar Link	pending
onesix_ex311.htm	Edgar Link	pending
onesix_ex312.htm	Edgar Link	pending
onesix_ex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
onesix-20231231_def.xml	Edgar Link	unprocessable
onesix-20231231_lab.xml	Edgar Link	unprocessable
onesix-20231231_pre.xml	Edgar Link	unprocessable
onesix_10k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
onesix-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBDW
1606 CORP. Stock $cbdw

2024 Q2 Form 10-K Financial Statement

#000147793224002182 Filed on April 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBDW 1606 CORP. Stock $cbdw

2024 Q2 Form 10-K Financial Statement

#000147793224002182 Filed on April 17, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBDW
1606 CORP. Stock $cbdw